In our observation, KHDRBS3-silenced cells exhibited low lactate production and glucose uptake and attenuated resistance to doxorubicin, suggesting that knockdown of KHDRBS3 reduces the glycolysis level and attenuates drug resistance in HCC cells. Here, KHDRBS3 is linked to hepatocellular carcinoma.